What did CDC pause testing for rabies and mpox?

CDC pauses testing for rabies and mpox in some programs

The CDC has paused testing for rabies and mpox by removing them from a list of tests the agency conducts for state and local health departments. The change comes amid concern that drastic staffing reductions could limit the ability of public health labs to support routine or emergency testing capacity.

What changed

The reporting indicates that rabies and mpox were removed from the CDC’s slate of tests that are performed for state and local partners. This does not mean the diseases themselves are gone; rather, it changes the laboratory support structure for how local agencies get confirmatory or specialized testing.

Why it matters

For public health surveillance and outbreak response, the CDC’s testing role can be critical, especially for rare or high-consequence situations. When national support is reduced, states may have to rely more heavily on their own lab capacity, alternative testing pathways, or partners outside the CDC system.

Experts cited in the coverage worry that staffing cuts could mean the paused testing reflects reduced operational capacity, which could slow verification and complicate response.

What remains unknown from the summary

The provided story does not specify:

• how long the pause will last
• which jurisdictions are most affected
• what alternative confirmatory testing arrangements are available

The main takeaway is that CDC laboratory support for these two conditions has been reduced, raising practical concerns for local outbreak management.

In the context of ongoing public health pressures and workforce constraints, the move highlights how reductions in federal capacity can ripple down to local disease detection and response.